Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2010
05/12/2010EP2183218A2 Novel b1 antagonists
05/12/2010EP2183201A1 Process for the resolution of zopiclone and intermediate compounds
05/12/2010EP2183027A1 Organic compounds
05/12/2010EP2049519B1 Cyclic derivatives as modulators of chemokine receptor activity
05/12/2010EP1899350B1 Pyrazolo [3 , 4-d]azepine derivatives as histamine h3 antagonists
05/12/2010EP1899343B1 Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates
05/12/2010EP1519933B1 Quinuclidine amide derivatives
05/12/2010CN1823038B Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
05/12/2010CN1809572B Substituted quinobenzoxazine analogs
05/12/2010CN101704820A 3-(4-chlorphenyl) carbazole compound and synthesis method thereof
05/12/2010CN101704819A Purifying method of 3,7-binitro-1,3,5,7-diazabicyclo[3,3,1]nonane
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/12/2010CN101153041B 1,2,3-triazole 1,3-nitrogen heterocyclic compound, producing method and application of the same
05/12/2010CN101113150B Method for synthesizing bicycle aza ring fluorescent or phosphorescent compound
05/11/2010US7714018 Heterocyclic antiviral compounds
05/11/2010US7714010 N-[5-(2-Cyclopropoxy-ethyl)-7,7-dimethyl-6-oxo-3,5,6,7-tetrahydro-imidazo[4,5-f]indol-2-yl]-benzamide; tubulin-binding molecules
05/11/2010US7713981 Method and compounds for inhibition of cell death
05/11/2010US7713975 Syk-mediated disease such as allergic conjunctivitis; vernal conjunctivitis; vernal keratoconjunctivitis; and giant papillary conjunctivitis
05/11/2010US7713974 3-chloro-5-[6-chloro-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)-phenoxy]-benzonitrile; inhibit HIV reverse transcriptase and are useful for treating Human Immunodeficiency Virus (HIV) mediated diseases
05/11/2010US7713973 Kinase inhibitors
05/11/2010US7713972 Imidazotriazinone derivatives as PDE 7 (phosphodiesterase 7) inhibitors
05/11/2010US7713969 Compositions and methods for treatment of cancer
05/11/2010US7713964 Methods for treating asthmatic conditions
05/11/2010US7713958 Compounds and compositions as protein kinase inhibitors
05/11/2010US7713954 Compositions and methods for treating cognitive disorders
05/11/2010CA2503663C Novel quinoxalinone derivatives
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2326324C Nitrogen-containing heterocyclic compound
05/11/2010CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
05/06/2010WO2010050525A1 Compound having tafia inhibitory activity
05/06/2010WO2010050496A1 Nitrogen-containing heterocyclic derivative and organic electroluminescence element using nitrogen-containing heterocyclic derivative
05/06/2010WO2010050456A1 Piperidine compound having di- or tri-arylmethyl structure
05/06/2010WO2010049525A1 Choline and tromethamine salt of licofelone
05/06/2010WO2010027746A3 Hedgehog pathway modulators
05/06/2010WO2009155527A9 Phosphatidylinositol 3 kinase inhibitors
05/06/2010WO2009151997A8 Process for producing bicycloaniline derivatives
05/06/2010US20100113482 Novel Compounds for Treating Mental Disorders, and Preparation and Uses Thereof
05/06/2010US20100113478 Indolone modulators of 5-ht3 receptor
05/06/2010US20100113460 Organic Compounds
05/06/2010US20100113458 Imidazopyridazinecarbonitriles useful as kinase inhibitors
05/06/2010US20100113441 Substituted imidazopyrimidines and triazolopyrimidines
05/06/2010US20100113425 Pyrrolobenzodiazepines
05/06/2010US20100113422 Pyrimido [4,5-D] Azepine Derivatives As 5-HT2C Agonists
05/06/2010US20100113420 Pyrrolopyrimidine derivatives as jak3 inhibitors
05/06/2010US20100113410 Pyrazolopyrimidine derivative
05/06/2010CA2742322A1 Azepino[4,5-b]indoles and methods of use
05/06/2010CA2741941A1 Choline and tromethamine salt of licofelone
05/06/2010CA2741783A1 Compounds having tafia inhibitory activity
05/05/2010EP2181992A1 Polycyclic compound
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010EP1232157B1 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
05/05/2010CN1832925B New P2X7 receptor avtagonists and their use
05/04/2010US7709644 enantiomeric enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane with the aid of continuous countercurrent chromatography, nuclear hydrogenation of pyridine-2,3-dicarboxylic acid-N-benzylimide
05/04/2010US7709637 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi
05/04/2010US7709633 Ink formulations comprising gallium naphthalocyanines
05/04/2010US7709500 Chemical compounds
05/04/2010US7709497 Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
05/04/2010US7709492 Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
05/04/2010US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/04/2010US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010US7709473 5-[2-(6-tert-Butyl-3-oxo-2,3-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-ylamino)-ethoxy]-nicotinic acid methyl ester; inhibitors of glycogen synthase kinase 3 (GSK-3); diabetes, dementia, Alzheimer's Disease, bipolar disorder, stroke, schizophrenia, depression, hair loss, cancer
05/04/2010US7709468 Imidazo based heterocycles
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
05/04/2010CA2414200C Variolin derivatives as anti-cancer agents
05/04/2010CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
04/2010
04/29/2010WO2010048564A1 Modulators of cystic fibrosis transmembrane conductance regulator
04/29/2010WO2010048326A1 Isoelectronic heteroanalogues of pcbm and c60 for n-bridged pcbms for organic electronic material
04/29/2010WO2010047956A1 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists
04/29/2010WO2010047864A1 Liquid crystalline blends, device thereof and method thereof
04/29/2010WO2010047611A1 Process for preparing chlorins and their pharmaceutical uses
04/29/2010WO2010046517A1 Compounds promoting the activity of mutant glycosidases
04/29/2010WO2010046273A2 Pyrimidinyl pyridone inhibitors of jnk
04/29/2010WO2010046259A1 Polycyclic compounds for electronic applications
04/29/2010WO2010046109A1 Pyrimidine and triazine sulfonamide derivates as b1 bradykinin receptor (b1r) inhibitors for treating pain
04/29/2010WO2010008828A3 Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds
04/29/2010WO2010003475A3 Novel pyrrolidone derivatives for use as metap-2 inhibitors
04/29/2010WO2009026446A8 Hdac inhibitors
04/29/2010US20100105922 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
04/29/2010US20100105915 Chemokine receptor binding heterocyclic compounds
04/29/2010US20100105903 Method for the production of beta-ketonitriles
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105725 Antidiabetic bicyclic compounds
04/29/2010US20100105708 Pyrrolopyrimidines for pharmaceutical compositions
04/29/2010US20100105704 7-(3',4'-Dialkoxyphenyl)-[1,2,4]-Triazolo[1,5-A]Pyrimidine Compounds, Process for Preparing Thereof, and Pharmaceutical Composition for Treating or Preventing Asthma, Chronic Obstructive Pulmonary Disease, Arthritis, Atopic Dermatitis, Tumor and Degenerative Brain Diseases Comprising the Same
04/29/2010US20100105676 Fused heterocyclic compounds useful as kinase modulators
04/29/2010US20100105666 Triazabenzo (a)naphtho(2,1,8-cde) azulene compounds.
04/29/2010US20100105654 Substituted quinazolinone compounds
04/29/2010US20100105653 Pyrrolopyrimidine compounds and their uses
04/29/2010US20100105652 Purines as cysteine protease inhibitors
04/29/2010CA2742042A1 Modulators of cystic fibrosis transmembrane conductance regulator
04/29/2010CA2741349A1 Pyrimidine and triazine sulfonamide derivates as b1 bradykinin receptor (b1r) inhibitors for treating pain
04/29/2010CA2734037A1 Pyrimidinyl pyridone inhibitors of jnk
04/28/2010EP2178881A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors
04/28/2010EP2178880A1 Process for the synthesis of e1 activating enzyme inhibitors
04/28/2010EP2178879A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
04/28/2010EP2178878A1 Tetracyclic compounds for the treatment of hepatitis c
04/28/2010EP2178877A1 Anti-viral compounds, compositions, and methods of use
04/28/2010EP2178874A1 Heterocyclic compounds useful as mk2 inhibitors
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 573